Denali Therapeutics (DNLI) stock jumps on FDA approval of the company's lead asset, Avlayah developed with Royalty Pharma ...
The FDA has granted accelerated approval to Avlayah (tividenofusp alfa-eknm) for neurologic manifestations of Hunter syndrome in pediatric patients.
Clinical decision support (CDS) software plays an increasingly central role in health-care delivery, yet the ambiguous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results